REFERENCES R61
somatoform disorders with St. John’s wort:
A randomized, double-blind and placebo-
controlled trial. Psychosomatic Medicine, 66,
538–547.
Mulvany, F., O’Callaghan, E., Takei, N.,
Byrne, M., Fearon, P., & Larkin, C. (2001).
Effect of social class at birth on risk and
presentation of schizophrenia: Case-control
study. BMJ: British Medical Journal, 323 ,
1398–1401.
Munafò, M. R., Clark, T. G., Roberts, K. H., &
Johnstone, E. C. (2006). Neuroticism
mediates the association of the serotonin
transporter gene with lifetime major
depression.Neuropsychobiology, 53, 1–8.
Mundo, E., Richter, M. A., Sam, F.,
Macciardi, F., & Kennedy, J. L. (2000). Is
the 5-HT-sub(1Dß) receptor gene implicated
in the pathogenesis of obsessive-compulsive
disorder?American Journal of Psychiatry,
157,1160–1161.
Mundo, E., Walker, M., Tims, H., Macciardi,
F., & Kennedy, J. L. (2000). Lack of linkage
disequilibrium between serotonin transporter
protein gene (SLC6A4) and bipolar disorder.
American Journal of Medical Genetics, 96,
379–383.
Munroe, R. L. & Gauvain, M. (2001). Why
the paraphilias? Domesticating strange sex.
Cross-Cultural Research: The Journal of
Comparative Social Science, 35, 44–64.
Murias, M. A., Webb, S. J., Merkle,
K., Greenson, J., & Dawson, G. (2006,
October 14). Spontaneous EEG coherence
in adults with autism. Poster presented at
Neuroscience 2006 Georgia World Congress
Center..
Murphy, L. J., & Mitchell, D. L. (1998).
When writing helps to heal: E-mail as
therapy. British Journal of Guidance and
Counseling, 26, 21–32
Murray, C. J. L., & Lopez, A. D. (Eds.).
(1996).The global burden of disease. A
comprehensive assessment of mortality
and disability from diseases, injuries, and
risk factors in 1990 and projected to 2020.
Cambridge, MA: Harvard School of Public
Health.
Murray, H. A. (1943).Thematic
Apperception Test manual. Cambridge, MA:
Harvard University Press.
Murray, L. A., Whitehouse, W. G., &
Alloy, L. B. (1999). Mood congruence and
depressive defi cits in memory: A forced-recall
analysis.Memory, 7, 175–196.
Myers, J. E. B. (1998). Legal issues in child
abuse and neglect practice. Thousand Oaks,
CA: Sage.
Myin-Germeys, I., Delespaul, P. A. E. G., &
deVries, M. W. (2000). Schizophrenia
patients are more emotionally active
than is assumed based on their behavior.
Schizophrenia Bulletin, 26, 847–853.
Nahas, Z., Kozel, F. A., Li, X., Anderson,
B., & George, M. S. (2003). Left prefrontal
transcranial magnetic stimulation (TMS)
treatment of depression in bipolar affective
disorder: A pilot study of acute safety and
effi cacy. Bipolar Disorders, 5 , 40–47.
Nahas, Z., Kozel, F. A., Li, X., Anderson,
B., George, M. S. (2003). Left prefrontal
transcranial magnetic stimulation (TMS)
treatment of depression in bipolar affective
disorder: A pilot study of acute safety and
effi cacy. Bipolar Disorders, 5, 40–47.
Nathan, P. E., Skinstad, A. H., & Dolan,
S. L. (2000). Clinical psychology II.
Psychological treatments: Research and
practice. In K. Pawlik & M.R. Rosenzweig
(Eds.),International handbook of psychology
(pp. 429–451). Thousand Oaks, CA: Sage
Publications.
Nathan, P. E., Stuart, S. P., & Dolan, S.
L. (2000). Research on psychotherapy
effi cacy and effectiveness: Between Scylla
and Charybdis? Psychological Bulletin, 126,
964–981.
National Center for Health Statistics. (2008).
Diagnosed attention defi cit hyperactivity
disorder and learning disability: United
States, 2004–2006. DHHS Publication
No. (PHS) 2008-1565, Series 10, No. 237.
Retrieved on February 15, 2009, from
http://www.cdc.gov/nchs/data/series/sr_10/
sr10_237.pdf
National Committee for Quality Assurance.
(2007).The state of health care quality 2007.
Washington, DC: Author.
National Depressive and Manic Depressive
Association. (2002).Suicide prevention.
Retrieved Month 00, 200X, from http://
http://www.ndmda.org/suicide.html
National Institute on Aging. (2003).
Alzheimer’s disease: Unraveling the mystery.
NIH Pub. No: 02-3782. Retrieved December
4, 2007, from http://www.nia.nih.gov/NR/
rdonlyres/A294D332-71A2-4866-BDD7-
A0DF216DAAA4/0/Alzheimers_Disease_
Unraveling_the_Mystery.pdf
National Institute on Alcohol Abuse and
Alcoholism, National Advisory Council.
(2004). NIAAA Council approves defi nition
of binge drinking. NIAAA Newsletter, 3.
Retrieved February 22, 2006, from http://
pubs.niaaa.nih.gov/publications/Newsletter/
winter2004/Newsletter_Number3.
htm#council
National Institute on Alcohol Abuse and
Alcoholism. (2005). What is alcoholism?
Retrieved December 12, 2005, from http://
http://www.niaaa.nih.gov/FAQs/General-English/
FAQ1.htm
National Institute on Drug Abuse (2000).
The brain: Understanding neurobiology
through the study of addiction. [NIH
Publication No. 00-4871]. Bethesda, MD:
Author.National Institute on Drug Abuse. (1999).
Principles of drug addiction treatment: A
research-based guide [NIH Publication No.
00-4180].Bethesda, MD: Author.
National Institute on Drug Abuse. (2001).
NIDA research report series: Hallucinogens
and dissociative drugs [NIH Publication
No. 01-4209]. Retrieved December 24,
2008, from http://www.drugabuse.gov/PDF/
PODAT/PODAT.pdf
National Institute on Drug Abuse. (2003).
Drug use among racial/ethnic minorities
[NIH Publication No. 03-3888]. Bethesda,
MD: Author.
National Institute on Drug Abuse. (2004).
NIDA research report series: Cocaine: Abuse
and addiction [NIH publication number
99-4342]. Bethesda, MD: Author.
National Institute on Drug Abuse. (2005a).
NIDA research report series: Heroin: Abuse
and addiction [NIH Publication No.
05-4165]. Bethesda, MD: Author.
National Institute on Drug Abuse. (2005b).
NIDA research report series: Marijuana
abuse [NIH publication number 05-3859].
Bethesda, MD: Author.
National Institute on Drug Abuse. (2005c).
NIDA research report series: Prescription
drugs: Abuse and addiction [NIH Publication
No. 05-4881]. Bethesda, MD: Author.
National Institute on Drug Abuse. (2006a).
NIDA InfoFacts: Costs to society. Retrieved
March 12, 2009, from http://www.
drugabuse.gov/Infofacts/costs.html
National Institute on Drug Abuse. (2006b).
NIDA InfoFacts: Methylphenidate (Ritalin).
Retrieved March 12, 2009, from http://www.
drugabuse.gov/Infofacts/ADHD.html
National Institute on Drug Abuse. (2006c).
NIDA research report series: Tobacco
addiction [NIH Publication No. 06-4342].
Bethesda, MD: Author.
National Institute on Drug Abuse. (2007a).
NIDA InfoFacts: Cigarettes and Other
Tobacco Products. Retrieved on March
12, 2009, from http://www.drugabuse.gov/
Infofacts/tobacco.html.
National Institute on Drug Abuse. (2007b).
NIDA InfoFacts: Crack and cocaine. Re-
trieved March 12, 2009, from http://www.
drugabuse.gov/Infofacts/cocaine.html.
National Institute on Drug Abuse. (2007c).
NIDA InfoFacts: Heroin. Retrieved March
12, 2009, from http://www.drugabuse.gov/
Infofacts/heroin.html.
National Institute on Drug Abuse. (2007d).
NIDA InfoFacts: LSD. Retrieved March 12,
2009, from http://www.drugabuse.gov/pdf/
infofacts/Hallucinogens08.pdf.
National Institute on Drug Abuse. (2007e).
NIDA InfoFacts: MDMA (Ecstasy).
Retrieved March 12, 2009, from http://www.
drugabuse.gov/Infofacts/ecstasy.html